Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00064844 · ClinicalTrials.gov registry record · Phase 4
Combination Nicotine Replacement for Alcoholic Smokers
A Phase 4 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 4
- Development phase
- 96
- Enrollment target
NCT00064844: Completed Phase 4 study, sponsored by Yale University.
NCT00064844 is a Phase 4 study that has completed, run by Yale University. The registered enrollment target is 96 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00064844, a Phase 4 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 96 participants
- Enrollment target
Study Summary
The overall objective of the study is to develop recommendations for treatment programs to help alcoholic smokers to stop smoking. A sample of 175 alcohol dependent cigarette smokers will be recruited from the community and treated in a 6-month outpatient alcohol and tobacco treatment program. The 175 patients will be divided into two groups. One group will receive an active nicotine patch and active nicotine gum. The other group will receive an active nicotine patch and placebo nicotine gum. Followup assessments will be conducted for 1-year from the beginning of treatment.
Primary Outcome
Percentage of participants with prolonged carbon monoxide verified smoking abstinence
Interventions
- DRUG Nicoderm CQ nicotine patch
- BEHAVIORAL Cognitive Behavior Therapy for alcohol and smoking cessation
- DRUG Placebo gum
- DRUG Nicotine gum - Nicorette®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2002-08 |
| Est. Completion | 2006-07 |
| Phase | Phase 4 |
What the finished NCT00064844 record still lists
NCT00064844 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 4 interventions - of which Nicoderm CQ nicotine patch is the first listed.
NCT00064844 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00064844 about?
NCT00064844 is a clinical study titled "Combination Nicotine Replacement for Alcoholic Smokers". The overall objective of the study is to develop recommendations for treatment programs to help alcoholic smokers to stop smoking. A sample of 175 alcohol dependent cigarette smokers will be recruited from the community and treated in a 6-month outpatient alcohol and tobacco treatment program. The 1...
What is the current status of trial NCT00064844?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 96 participants. The study started on 2002-08. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00064844?
The interventions under investigation include: Nicoderm CQ nicotine patch (DRUG), Cognitive Behavior Therapy for alcohol and smoking cessation (BEHAVIORAL), Placebo gum (DRUG), Nicotine gum - Nicorette® (DRUG).
Who is sponsoring clinical trial NCT00064844?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00064844's enrollment target sits among peer trials
96 863rd of 2000 higher than 1,132 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia